ORTEXORTEX News
Tracking NUE? Get live short interest, options flow, and signals on ORTEX.Sign up free →
NU
ConfluenceNUE

Analysts Trim Targets as Options Traders Bet on NUE Upside

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 18 Sept 2026, 15:19

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Two analyst cuts landed on NUE today. The divergence between those downgrades and where options traders are positioned makes this a story worth watching.

Analysts Turn Cautious

Freedom Broker downgraded Nucor to Hold from Buy this morning. The price target dropped to $285 from $305. That implies roughly 7.5% upside from Wednesday's $265.14 close — hardly a compelling risk/reward for a conviction call.

Wells Fargo stayed at Overweight but also trimmed. Analyst Timna Tanners cut her target to $280 from $285, the second reduction she has made in six weeks. Her prior cut, in late August, took it from $297 to $285.

JP Morgan went the other way on September 9. Bennett Moore raised his Overweight target to $308 from $294. The mean analyst price target now sits at $285.19.

Options Market Disagrees

The put-call ratio on NUE stood at 0.81 as of September 17. That is near the 52-week high of 0.85 hit on September 16. The 20-day average is 0.68. A rising PCR can reflect growing put demand — a hedge — or simply heavier call volume denominator effects. Here, the ratio has climbed sharply in a week where the stock was up 3.8%. That pattern leans more toward hedging than outright bearishness.

The borrow market offers no signal either way. Availability is effectively unconstrained — shares to borrow vastly exceed current short positions. Cost to borrow sits at 0.39%, up 22% week-on-week but still negligible in absolute terms.

Short Interest: Rising but Modest

Short interest climbed 16.8% over the past week to 1.83% of free float. That is a notable pace of increase. The absolute level, however, remains low. Bears added roughly 560,000 shares in a single session around September 9. Since then, positions have held roughly flat. At 1.83% of float, short sellers are not making a structural bet against the company.

CEO Sales Add a Layer

CEO Leon Topalian sold ~$6.98 million worth of shares on August 14, exercising options and selling the resulting stock. President and COO Stephen Laxton sold ~$1.02 million on July 30. None of these sales were flagged as pre-arranged 10b5-1 plan trades. Net insider activity over 90 days is -$17.3 million in value.

Earnings are due October 26. The stock has moved an average of more than 5% in the five sessions following each of the last four prints.


What to watch: Whether Wells Fargo's Timna Tanners — who has trimmed twice since July — cuts again after Q3 results, and whether the elevated put-call ratio resolves as a hedge unwind or genuine directional pressure.

  • Price (Sep 17): $265.14, +1.7% on the day, +3.8% on the week
  • SI % FF: 1.83%, up 16.8% week-on-week
  • Cost to borrow: 0.39% (negligible)
  • Availability: Unconstrained (9,999%+ of SI)
  • PCR: 0.81 vs 0.68 20-day mean; 52-week high 0.85
  • Mean analyst PT: $285.19 | Freedom Broker PT: $285 (downgrade to Hold) | Wells Fargo PT: $280 (Overweight)
  • Net insider selling (90d): –$17.3M
  • Next earnings: October 26, 2026

Stocks in this article

See the live data behind this article on ORTEX.

Open NUE on ORTEX →

How this article was generated

Generated
18 Sept 2026, 15:24
Data as of
18 Sept 2026, 15:19
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.